These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells. Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213 [TBL] [Abstract][Full Text] [Related]
26. Evidence for dimeric BACE-mediated APP processing. Jin S; Agerman K; Kolmodin K; Gustafsson E; Dahlqvist C; Jureus A; Liu G; Fälting J; Berg S; Lundkvist J; Lendahl U Biochem Biophys Res Commun; 2010 Feb; 393(1):21-7. PubMed ID: 20097169 [TBL] [Abstract][Full Text] [Related]
27. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions. Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541 [TBL] [Abstract][Full Text] [Related]
28. Expression of APP pathway mRNAs and proteins in Alzheimer's disease. Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478 [TBL] [Abstract][Full Text] [Related]
29. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052 [TBL] [Abstract][Full Text] [Related]
30. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice. Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629 [TBL] [Abstract][Full Text] [Related]
31. Effects of peptides derived from BACE1 catalytic domain on APP processing. Yeon SW; Jeon YJ; Hwang EM; Kim TY Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005 [TBL] [Abstract][Full Text] [Related]
32. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Yu WH; Kumar A; Peterhoff C; Shapiro Kulnane L; Uchiyama Y; Lamb BT; Cuervo AM; Nixon RA Int J Biochem Cell Biol; 2004 Dec; 36(12):2531-40. PubMed ID: 15325590 [TBL] [Abstract][Full Text] [Related]
33. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
34. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Rakover I; Arbel M; Solomon B Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186 [TBL] [Abstract][Full Text] [Related]
36. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Rossner S; Sastre M; Bourne K; Lichtenthaler SF Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810 [TBL] [Abstract][Full Text] [Related]
37. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related]
39. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice. Nishitomi K; Sakaguchi G; Horikoshi Y; Gray AJ; Maeda M; Hirata-Fukae C; Becker AG; Hosono M; Sakaguchi I; Minami SS; Nakajima Y; Li HF; Takeyama C; Kihara T; Ota A; Wong PC; Aisen PS; Kato A; Kinoshita N; Matsuoka Y J Neurochem; 2006 Dec; 99(6):1555-63. PubMed ID: 17083447 [TBL] [Abstract][Full Text] [Related]
40. A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage. Lai MT; Crouthamel MC; DiMuzio J; Pietrak BL; Donoviel DB; Bernstein A; Gardell SJ; Li YM; Hazuda D J Neurochem; 2006 Jan; 96(1):118-25. PubMed ID: 16300640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]